Promising efficacy and safety profile reported for DMP-450 at 24 weeks in ongoing phase I/II trial April 19, 2001
Korean research suggests potential in HPV-associated cervical cancer for new arsenic compound April 18, 2001
AACR presentations describe design and biological activity of new CDK inhibitor NU-6102 April 18, 2001